Preclinical validation of AXL receptor as a target for antibody-based pancreatic cancer immunotherapy
AXL 受体作为抗体型胰腺癌免疫治疗靶点的临床前验证
期刊:Oncogene
影响因子:6.9
doi:10.1038/onc.2013.487
W Leconet, C Larbouret, T Chardès, G Thomas, M Neiveyans, M Busson, M Jarlier, N Radosevic-Robin, M Pugnière, F Bernex, F Penault-Llorca, J-M Pasquet, A Pèlegrin, B Robert
